Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.
BACKGROUND: Women are at great risk for mood and anxiety disorders during their childbearing years and may become pregnant while taking antidepressant drugs. In the treatment of depression and anxiety disorders, selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed drugs...
Main Authors: | Cornelle W Noorlander, Frederique F T Ververs, Peter G J Nikkels, Cees J A van Echteld, Gerard H A Visser, Marten P Smidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2518512?pdf=render |
Similar Items
-
Correction: Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities
by: Cornelle W. Noorlander, et al.
Published: (2009-01-01) -
Correction: Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities.
by: Cornelle W. Noorlander, et al.
Published: (2009-01-01) -
Endocrine abnormalities in dilated cardiomyopathy
by: Ankit Jain, et al.
Published: (2015-01-01) -
Dilated cardiomyopathy
by: McKenna, Charles J.
Published: (1999) -
Takotsubo cardiomyopathy (TCM) versus dilated cardiomyopathy (DCM)
by: A. Lalchandani, et al.
Published: (2014-11-01)